Author： Jabbour Elias Kantarjian Hagop Cortes Jorge
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.3, 2007-03, pp. : 381-392
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Immunotoxins in the Treatment of Hematologic Malignancies
Current Drug Targets, Vol. 7, Iss. 10, 2006-01 ,pp. :
Antiangiogenic Therapy in Hematologic Malignancies
Current Pharmaceutical Design, Vol. 10, Iss. 11, 2004-04 ,pp. :
Ras as a therapeutic target in hematologic malignancies
By Alvarado Yesid Giles Francis J
Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. :
Invasive Aspergillosis in Children with Hematologic Malignancies
By Hasan Rashed A. Abuhammour Walid
Pediatric Drugs, Vol. 8, Iss. 1, 2006-01 ,pp. :